U.S. markets open in 1 hour 16 minutes

Acrivon Therapeutics, Inc. (ACRV)

NasdaqGM - NasdaqGM Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
7.39+0.08 (+1.09%)
Al cierre: 04:00PM EDT
Accionistas principales
Nómina de miembros de la gerencia

Transacciones de miembros de la gerencia

Divisa en USD
Compras de miembros de la gerencia en los últimos 6 mesesAccionesTrans
Compras00
VentasN/D0
Acciones netas compradas (vendidas)00
Acciones totales pertenecientes a miembros de la gerencia7.08MN/D
Acciones netas compradas (vendidas) en %N/DN/D
Compras institucionales netas del trimestre anterior al últimoAcciones
Acciones netas compradas (vendidas)N/D
Cambio en acciones institucionales propias en %N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerenciaTransacciónTipoValorFechaAcciones

DEVROE ERIC
Chief Operating Officer

Conversion of Exercise of derivative security at price 1.04 per share.Directo10,40017 may 202410,000

PERCEPTIVE ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 8.50 per share.Indirecto20,000,50011 abr 20242,353,000

RA CAPITAL MANAGEMENT, L.P.
Beneficial Owner of more than 10% of a Class of Security

Stock Award(Grant) at price 8.50 per share.Indirecto30,005,00011 abr 20243,530,000

MILLER MARY
Officer

Stock Award(Grant) at price 0.00 per share.Directo026 sept 20233,858

BLUME-JENSEN PETER
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Directo021 ago 2023493,994

CHIONE, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 12.93 per share.Indirecto20726 jun 202316

HOLM-JORGENSEN RASMUS
Chief Financial Officer

Conversion of Exercise of derivative security at price 3.63 per share.Directo34,48516 jun 20239,500

CHIONE, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 12.14 per share.Indirecto24,96015 jun 20232,056

CHIONE, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 12.13 - 12.34 per share.Indirecto72,41214 jun 20235,893

DEVROE ERIC
Chief Operating Officer

Conversion of Exercise of derivative security at price 1.04 per share.Directo9,59405 jun 20239,225

BLUME-JENSEN PETER
Chief Executive Officer

Conversion of Exercise of derivative security at price 3.88 per share.Directo130,38731 may 202333,605

CHIONE, LTD.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 15.72 per share.Indirecto6,288,00017 nov 2022400,000

CHIONE, LTD.
Beneficial Owner of more than 10% of a Class of Security

Indirecto17 nov 20223,456,597

RA CAPITAL MANAGEMENT, L.P.
Director and Beneficial Owner of more than 10% of a Class of Security

Purchase at price 15.72 per share.Indirecto53,282,94017 nov 20223,389,500

RA CAPITAL MANAGEMENT, L.P.
Director and Beneficial Owner of more than 10% of a Class of Security

Indirecto17 nov 20221,421,008

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN I L
Beneficial Owner of more than 10% of a Class of Security

Directo17 nov 2022888,130

DEVROE ERIC
Chief Operating Officer

Directo14 nov 202233,383

BLUME-JENSEN PETER
Chief Executive Officer

Indirecto14 nov 20221,524,947

MASSON KRISTINA
Officer and Director

Indirecto14 nov 20221,524,947

HOLM-JORGENSEN RASMUS
Chief Financial Officer

Directo14 nov 202220,030

GAMELIN ERICK
Officer

Directo14 nov 202220,030